Brought to you by 
Wyeth-Ayerst licenses Metra's bone test marker
13 Jul 1999
Executive Summary
Metra Biosystems has non-exclusively licensed to American Home Products's Wyeth-Ayerst its Pyrilinks urinary assay that measures the excretion of deoxypyridinoline crosslinks as an indicator of bone type I collagen resorption.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
- Pharmaceuticals
-
In Vitro Diagnostics
- Urine-based Testing
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Wyeth-Ayerst licenses Metra's bone test marker
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice